Łabuzek B - Search Results

1

NMR fragment-based screening for development of the CD44-binding small molecules.

Pustuła M, Czub M, Łabuzek B, Surmiak E, Tomala M, Twarda-Clapa A, Guzik K, Popowicz GM, Holak TA. Pustuła M, et al. Among authors: labuzek b. Bioorg Chem. 2019 Feb;82:284-289. doi: 10.1016/j.bioorg.2018.10.043. Epub 2018 Oct 25. Bioorg Chem. 2019. PMID: 30396062

2

1,4,5-Trisubstituted Imidazole-Based p53-MDM2/MDMX Antagonists with Aliphatic Linkers for Conjugation with Biological Carriers.

Twarda-Clapa A, Krzanik S, Kubica K, Guzik K, Labuzek B, Neochoritis CG, Khoury K, Kowalska K, Czub M, Dubin G, Dömling A, Skalniak L, Holak TA. Twarda-Clapa A, et al. Among authors: labuzek b. J Med Chem. 2017 May 25;60(10):4234-4244. doi: 10.1021/acs.jmedchem.7b00104. Epub 2017 May 16. J Med Chem. 2017. PMID: 28482147

3

Crystal structure of the FAS1 domain of the hyaluronic acid receptor stabilin-2.

Twarda-Clapa A, Labuzek B, Krzemien D, Musielak B, Grudnik P, Dubin G, Holak TA. Twarda-Clapa A, et al. Among authors: labuzek b. Acta Crystallogr D Struct Biol. 2018 Jul 1;74(Pt 7):695-701. doi: 10.1107/S2059798318007271. Epub 2018 Jun 27. Acta Crystallogr D Struct Biol. 2018. PMID: 29968679

4

A fluorinated indole-based MDM2 antagonist selectively inhibits the growth of p53^wt osteosarcoma cells.

Skalniak L, Twarda-Clapa A, Neochoritis CG, Surmiak E, Machula M, Wisniewska A, Labuzek B, Ali AM, Krzanik S, Dubin G, Groves M, Dömling A, Holak TA. Skalniak L, et al. Among authors: labuzek b. FEBS J. 2019 Apr;286(7):1360-1374. doi: 10.1111/febs.14774. Epub 2019 Feb 16. FEBS J. 2019. PMID: 30715803 Free PMC article.

5

Multicomponent Peptide Stapling as a Diversity-Driven Tool for the Development of Inhibitors of Protein-Protein Interactions.

Ricardo MG, Ali AM, Plewka J, Surmiak E, Labuzek B, Neochoritis CG, Atmaj J, Skalniak L, Zhang R, Holak TA, Groves M, Rivera DG, Dömling A. Ricardo MG, et al. Among authors: labuzek b. Angew Chem Int Ed Engl. 2020 Mar 23;59(13):5235-5241. doi: 10.1002/anie.201916257. Epub 2020 Feb 6. Angew Chem Int Ed Engl. 2020. PMID: 31944488

6

Design of indole- and MCR-based macrocycles as p53-MDM2 antagonists.

Neochoritis CG, Kazemi Miraki M, Abdelraheem EMM, Surmiak E, Zarganes-Tzitzikas T, Łabuzek B, Holak TA, Dömling A. Neochoritis CG, et al. Among authors: labuzek b. Beilstein J Org Chem. 2019 Feb 20;15:513-520. doi: 10.3762/bjoc.15.45. eCollection 2019. Beilstein J Org Chem. 2019. PMID: 30873235 Free PMC article.

7

Optimized Inhibitors of MDM2 via an Attempted Protein-Templated Reductive Amination.

van der Vlag R, Yagiz Unver M, Felicetti T, Twarda-Clapa A, Kassim F, Ermis C, Neochoritis CG, Musielak B, Labuzek B, Dömling A, Holak TA, Hirsch AKH. van der Vlag R, et al. Among authors: labuzek b. ChemMedChem. 2020 Feb 17;15(4):370-375. doi: 10.1002/cmdc.201900574. Epub 2019 Dec 12. ChemMedChem. 2020. PMID: 31774938 Free PMC article.

8

Nutlin-3a-aa: Improving the Bioactivity of a p53/MDM2 Interaction Inhibitor by Introducing a Solvent-Exposed Methylene Group.

Nietzold F, Rubner S, Labuzek B, Golik P, Surmiak E, Del Corte X, Kitel R, Protzel C, Reppich-Sacher R, Stichel J, Magiera-Mularz K, Holak TA, Berg T. Nietzold F, et al. Among authors: labuzek b. Chembiochem. 2023 Mar 14;24(6):e202300006. doi: 10.1002/cbic.202300006. Epub 2023 Feb 16. Chembiochem. 2023. PMID: 36602436

9

Experimental Evaluation of Shrinkage, Creep and Prestress Losses in Lightweight Aggregate Concrete with Sintered Fly Ash.

Szydłowski RS, Łabuzek B. Szydłowski RS, et al. Among authors: labuzek b. Materials (Basel). 2021 Jul 13;14(14):3895. doi: 10.3390/ma14143895. Materials (Basel). 2021. PMID: 34300814 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page